Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 332,069 | 219,788 | 137,039 | 94,085 | 62,649 |
| Cost of Goods | 60,205 | 44,982 | 32,009 | 15,822 | 9,685 |
| Gross Profit | 271,864 | 174,806 | 105,030 | 78,263 | 52,964 |
| Operating Expenses | 263,399 | 243,765 | 177,894 | 119,164 | 60,191 |
| Operating Income | 8,670 | -67,977 | -72,855 | -40,079 | -6,542 |
| Interest Expense | 577 | 11 | 17 | 1 | 2,634 |
| Other Income | 13,471 | 10,623 | 3,968 | 68 | -1,024 |
| Pre-tax Income | 21,564 | -57,365 | -68,904 | -40,012 | -10,200 |
| Income Tax | 3,319 | 101 | -1,766 | -8,720 | 84 |
| Net Income Continuous | 18,245 | -57,466 | -67,138 | -31,292 | -10,284 |
| Net Income | $18,245 | $-57,466 | $-67,138 | $-31,292 | $-10,284 |
| EPS Basic Total Ops | 0.66 | -2.14 | -2.58 | -1.24 | -0.54 |
| EPS Basic Continuous Ops | 0.66 | -2.14 | -2.58 | -1.24 | -0.54 |
| EPS Diluted Total Ops | 0.62 | -2.14 | -2.58 | -1.24 | -0.54 |
| EPS Diluted Continuous Ops | 0.62 | -2.14 | -2.58 | -1.24 | -0.54 |
| EPS Diluted Before Non-Recurring Items | 0.62 | -2.14 | -2.58 | -1.23 | -0.47 |
| EBITDA(a) | $17,982 | $-61,138 | $-63,680 | $-36,672 | $-5,231 |